Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Br J Nutr ; 127(2): 233-247, 2022 01 28.
Article in English | MEDLINE | ID: mdl-33143761

ABSTRACT

Vitamin C (ascorbic acid) is a water-soluble vitamin with an array of biological functions. A number of proposed factors contribute to the vitamin's plasma bioavailability and ability to exert optimal functionality. The aim of this review was to systematically assess plasma vitamin C levels post-surgery compared with pre-surgery/the magnitude and time frame of potential changes in concentration. We searched the PUBMED, SCOPUS, SciSearch and the Cochrane Library databases between 1970 and April 2020 for relevant research papers. Prospective studies, control groups and true placebo groups derived from controlled trials that reported means and standard deviations of plasma vitamin C concentrations pre- and postoperatively were included into the meta-analysis. Data were grouped into short-term (≤7 d) and long-term (>7 d) postoperative follow-up. Twenty-three of thirty-one studies involving 642 patients included in the systematic review were suitable for meta-analysis. Pooled data from the meta-analysis revealed a mean depletion of plasma vitamin C concentration of -17·99 µmol/l (39 % depletion) (CI -22·81, -13·17) (trial arms = 25, n 565, P < 0·001) during the first postoperative week and -18·80 µmol/l (21 % depletion) (CI -25·04, -12·56) (trial arms = 6, n 166, P < 0·001) 2-3 months postoperatively. Subgroup analyses revealed that these depletions occurred following different types of surgery; however, high heterogeneity was observed amongst trials assessing concentration change during the first postoperative week. Overall, our results warrant larger, long-term investigations of changes in postoperative plasma vitamin C concentrations and their potential effects on clinical symptomology.


Subject(s)
Ascorbic Acid , Vitamins , Humans , Prospective Studies
2.
Nutr Res Rev ; 32(1): 79-98, 2019 06.
Article in English | MEDLINE | ID: mdl-30378509

ABSTRACT

The proportion of adults aged 60 years and over is expected to increase over the coming decades. This ageing of the population represents an important health issue, given that marked reductions to cerebral macro- and microstructural integrity are apparent with increasing age. Reduced cerebral structural integrity in older adults appears to predict poorer cognitive performance, even in the absence of clinical disorders such as dementia. As such, it is becoming increasingly important to identify those factors predicting cerebral structural integrity, especially factors that are modifiable. One such factor is nutritional intake. While the literature is limited, data from available cross-sectional studies indicate that increased intake of nutrients such as B vitamins (for example, B6, B12 and folate), choline, n-3 fatty acids and vitamin D, or increased adherence to prudent whole diets (for example, the Mediterranean diet) predicts greater cerebral structural integrity in older adults. There is even greater scarcity of randomised clinical trials investigating the effects of nutritional supplementation on cerebral structure, though it appears that supplementation with B vitamins (B6, B12 and folic acid) or n-3 fatty acids (DHA or EPA) may be beneficial. The current review presents an overview of available research examining the relationship between key nutrients or adherence to select diets and cerebral structural integrity in dementia-free older adults.


Subject(s)
Aging , Brain/drug effects , Cognition/drug effects , Cognitive Dysfunction/prevention & control , Diet , Dietary Supplements , Aged , Aged, 80 and over , Choline/pharmacology , Choline/therapeutic use , Dementia/prevention & control , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-3/therapeutic use , Humans , Middle Aged , Polyphenols/pharmacology , Polyphenols/therapeutic use , Vitamins/pharmacology , Vitamins/therapeutic use
3.
Int J Psychophysiol ; 98(1): 95-111, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26166440

ABSTRACT

Whilst a number of previous studies have been conducted in order to investigate functional brain changes associated with eyes-closed meditation techniques, there is a relative scarcity in the literature with regards to changes occurring during eyes-open meditation. The current project used magnetoencephalography (MEG) to investigate differences in spectral power and functional connectivity between 11 long-term mindfulness meditators (LTMMs) with >5 years of experience and 12 meditation-naïve control participants both during baseline eyes-open rest and eyes-open open-monitoring (OM) mindfulness meditation. During resting with eyes-open, prior to meditating, greater mean alpha power was observed for LTMMs in comparison to controls. However, during the course of OM meditation, a significantly greater increase in theta power was observed over a broad fronto-centro-parietal region for control participants in comparison to LTMMs. In contrast, whole-head mean connectivity was found to be significantly greater for long-term meditators in comparison to controls in the theta band both during rest as well as during meditation. Additionally, mean connectivity was significantly lower for long-term meditators in the low gamma band during rest and significantly lower in both low and high gamma bands during meditation; and the variance of low-gamma connectivity scores for long-term meditators was significantly decreased compared to the control group. The current study provides important new information as to the trait functional changes in brain activity associated with long-term mindfulness meditation, as well as the state changes specifically associated with eyes-open open monitoring meditation techniques.


Subject(s)
Brain Mapping , Brain Waves/physiology , Brain/physiology , Mindfulness/methods , Anxiety/physiopathology , Anxiety/rehabilitation , Cluster Analysis , Electroencephalography , Eye , Female , Fourier Analysis , Humans , Longitudinal Studies , Magnetoencephalography , Male , Middle Aged , Rest , Surveys and Questionnaires
4.
Age (Dordr) ; 37(3): 9782, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25903286

ABSTRACT

A number of randomised controlled trials have indicated that multivitamin/mineral supplementation for a period of 4 weeks or greater can enhance mood and cognition. To date, no studies have investigated whether a single multivitamin dose can benefit mental function in older adults. This study investigated the acute effects of a single multivitamin and mineral and herbal (MVMH) supplement versus placebo on self ratings of mood and the performance of an effortful computerised cognitive battery in a sample of 76 healthy women aged 50-75 years. Mood was assessed using the depression anxiety stress scale (DASS), state trait anxiety inventory-state anxiety scale and visual analogue scales (VAS). Mood was rated at 1 h post supplementation and again after the competition of the cognitive assessments at 2 h post supplementation. It was demonstrated that the MVMH supplement improved overall DASS mood ratings; however, the most prominent effects appeared to be a reduction in ratings of perceived mental stress. These findings were confirmed using visual analogue scales, with these measures also demonstrating MVMH-related increased ratings of calmness. There were no benefits of the MVMH to mood ratings of depression and performance was not enhanced on the cognitive battery. Supplementation with a single multivitamin, mineral and herbal supplement reduces stress several hours after intake in healthy older people.


Subject(s)
Affect/drug effects , Cognition/drug effects , Minerals/administration & dosage , Phytotherapy , Vitamins/administration & dosage , Aged , Dietary Supplements , Female , Humans , Middle Aged , Psychiatric Status Rating Scales
5.
Appetite ; 69: 123-36, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23727255

ABSTRACT

Previous research has suggested that multivitamin (MV) supplementation may be associated with beneficial effects for mood and general well-being, although treatment durations have typically been less than 90 days, samples have often been restricted to males only and acute effects have not been adequately differentiated from chronic effects. In the current study a MV supplement containing high levels of B-vitamins was administered daily to 138 healthy young adult participants between the ages of 20 and 50 years over a 16-week period. Chronic mood measures (GHQ-28, POMS, Chalder fatigue, PILL, Bond-Lader and custom visual analogue scales) were administered pre-dose at baseline, 8- and 16-weeks. Changes in Bond-Lader and VAS in response to a multi-tasking framework (MTF) were also assessed at 8- and 16-weeks. For a subset of participants, at-home mobile-phone assessments of mood were assessed on a weekly basis using Bond-Lader and VAS. No significant treatment effects were found for any chronic laboratory mood measures. In response to the MTF, a significant treatment x time interaction was found for STAI-S, with a trend towards a greater increase in stress ratings for male participants in the MV group at 16 weeks. However, this finding may have been attributable to a larger proportion of students in the male MV group. In contrast, at-home mobile-phone assessments, where assessments were conducted post-dose, revealed significantly reduced stress, physical fatigue and anxiety in the MV group in comparison to placebo across a number of time points. Further research using both acute and chronic dosing regimens are required in order to properly differentiate these effects.


Subject(s)
Affect/drug effects , Dietary Supplements , Health Status , Vitamins/administration & dosage , Adult , Anxiety/prevention & control , Cell Phone , Double-Blind Method , Fatigue/prevention & control , Female , Humans , Male , Middle Aged , Placebos , Stress, Psychological/prevention & control , Surveys and Questionnaires , Young Adult
6.
Phytother Res ; 27(11): 1605-13, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23280675

ABSTRACT

The efficacy and tolerability of current treatments for smoking cessation are relatively poor. More research is required to address the biological mechanisms underpinning nicotine withdrawal and drug treatments for smoking cessation. We assessed the neurocognitive effects of Remotiv® (Hypericum perforatum Special Extract - Ze 117), Nicabate CQ Nicotine Replacement therapy (NRT) and combined NRT/HP during conditions of smoking abstinence in 20 regular smokers aged between 18 and 60 years over a period of 10 weeks during smoking cessation. A Spatial Working Memory (SWM) task was completed at baseline, 4 weeks prior to quitting, as well as at the completion of the study, following the 10 weeks of treatment. Brain activity was recorded during the completion of the SWM task using Steady-State Probe Topography. Reaction time and accuracy on the SWM task were not found to be significantly different between treatment groups at retest. Differences in SSVEP treatment profiles at retest are discussed, including stronger SSVEP Amplitude increase in posterior-parietal regions for the HP and NRT groups and greater fronto-central SSVEP Phase Advance in the HP group.


Subject(s)
Hypericum/chemistry , Memory, Short-Term/drug effects , Plant Extracts/pharmacology , Reaction Time/drug effects , Smoking Cessation/methods , Adolescent , Adult , Drug Therapy, Combination , Humans , Middle Aged , Nicotine/therapeutic use , Plant Extracts/therapeutic use , Reproducibility of Results , Substance Withdrawal Syndrome/drug therapy , Young Adult
7.
Traffic Inj Prev ; 14(1): 13-7, 2013.
Article in English | MEDLINE | ID: mdl-23259514

ABSTRACT

OVERVIEW: Increasing concerns over the potentially impairing effects of prescriptive sedative drugs such as benzodiazepines on driving have been raised. However, other alternatives such as natural medicines may also carry similar risks with respect to driving safety. Kava (Piper methysticum) is a psychotropic plant commonly used both recreationally and medicinally in the United States, Australia, and the South Pacific to elicit a physically tranquilizing effect. To date no controlled study has tested a medicinal dose of kava versus placebo and a standard sedative drug on driving ability and driving safety. OBJECTIVE: Due to the need to establish the safety of kava in operating a motor vehicle, we compared the acute effects of the plant extract versus the benzodiazepine oxazepam and placebo using a driving simulator. METHODS: A driving simulator (AusEd) was used by 22 adults aged between 18 and 65 years after being randomly administered an acute medicinal dose of kava (180 mg of kavalactones), oxazepam (30 mg), or placebo one week apart in a crossover design trial. RESULTS: No impairing effects on driving outcomes were found after kava administration compared to placebo. Results on specific driving outcome domains revealed that the oxazepam condition had significantly slower braking reaction time compared to the placebo condition (p =.002) and the kava condition (p =.003). The kava condition had significantly fewer lapses of concentration compared to the oxazepam condition (p =.033). No significant differences were found between conditions for steering deviation, speed deviation, and number of crashes. Results were not modified by driving experience. On the Bond-Lader visual analogue sub-scale of alertness, a significant Treatment × Time interaction (p =.032) was found, with a significant reduction over time for oxazepam decreasing alertness (p <.001), whereas no significant reduction was found in the kava or placebo conditions. CONCLUSION: The results indicate that a medicinal dose of kava containing 180 mg of kavalactones does not impair driving ability, whereas 30 mg of oxazepam shows some impairment. Research assessing larger recreational doses of kava on driving ability should now be conducted.


Subject(s)
Automobile Driving/psychology , Hypnotics and Sedatives/adverse effects , Kava/adverse effects , Plant Extracts/adverse effects , Psychomotor Performance/drug effects , Adolescent , Adult , Aged , Computer Simulation , Cross-Over Studies , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Middle Aged , Oxazepam/adverse effects , Young Adult
8.
Intern Med J ; 42(7): 808-15, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22151013

ABSTRACT

BACKGROUND: Although arterial stiffness has recently been confirmed as a predictor of cardiovascular disease, the association between arterial stiffness and cognitive decline is less clear. AIM: We performed a systematic review and meta-analysis to examine the evidence for large artery stiffness as a cause of cognitive decline and dementia. METHOD: Electronic databases were systematically searched until September 2011 for studies reporting on the longitudinal relationship between any validated measure of large artery stiffness and cognitive decline or dementia. Meta-analysis was performed on four studies investigating the association between aortic pulse wave velocity and a decline in Mini-Mental State Examination scores. RESULTS: Six relevant longitudinal studies were located, conducted over an average of 5 years follow up. Arterial stiffness was predictive of cognitive decline in five/six studies. In meta-analysis, higher aortic stiffness predicted lower Mini-Mental State Examination scores within the sample (ß=-0.03, 95% confidence interval (CI): -0.06 to 0.01, n= 3947), although studies were not all homogeneous, and statistical heterogeneity was present (I(2) = 71.9%, P= 0.01). Removal of one study with a relatively younger cohort and lower median aortic stiffness found higher aortic stiffness to significantly predict cognitive decline (ß=-0.04, 95% CI: -0.07 to -0.01, n= 3687) without evidence of heterogeneity (I(2) = 9.5%, P= 0.33). There was little research investigating the effects of aortic stiffness on the development of dementia. CONCLUSION: Aortic stiffness was found to predict cognitive decline in both qualitative review and quantitative analysis.


Subject(s)
Cognition Disorders/epidemiology , Dementia/epidemiology , Vascular Stiffness , Cognition Disorders/pathology , Cognition Disorders/psychology , Dementia/pathology , Dementia/psychology , Humans , Longitudinal Studies
9.
Physiol Behav ; 105(4): 948-57, 2012 Feb 28.
Article in English | MEDLINE | ID: mdl-22120044

ABSTRACT

In a randomized, double-blind placebo controlled trial, 63 middle-aged volunteers aged between 40 and 65 years were administered a daily chocolate drink containing 250 mg or 500 mg cocoa flavanols versus a low cocoa flavanol (placebo) drink over a 30-day period. Participants were tested at baseline as well as at the end of the treatment period on a test of Spatial Working Memory. Steady State Probe Topography (SST) was used to assess neurocognitive changes associated with cocoa flavanol supplementation during the completion of the Spatial Working Memory task. SST is an electrophysiological technique which utilizes a 13 Hz diffuse visual flicker in order to generate a steady state visually evoked potential (SSVEP). Changes in the amplitude and phase of the SSVEP response after 30 days were compared between treatment groups. Behavioral measures of accuracy and reaction time were not found to be significantly different between treatment groups, while average SSVEP amplitude and phase differences at a number of posterior parietal and centro-frontal sites were found to be significantly different between groups during memory encoding, the working memory hold period and retrieval. In the absence of significant behavioral effects, these differences in brain activation can be interpreted as evidence of increased neural efficiency in spatial working memory function associated with chronic cocoa flavanol consumption.


Subject(s)
Beverages , Cacao , Evoked Potentials, Visual/drug effects , Flavonoids/pharmacology , Memory, Short-Term/drug effects , Nootropic Agents/pharmacology , Adult , Aged , Dose-Response Relationship, Drug , Double-Blind Method , Evoked Potentials, Visual/physiology , Female , Flavonoids/administration & dosage , Flavonols/pharmacology , Humans , Male , Memory, Short-Term/physiology , Middle Aged , Nootropic Agents/administration & dosage , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Reaction Time/drug effects , Reaction Time/physiology
10.
Article in English | MEDLINE | ID: mdl-21941584

ABSTRACT

Ginkgo Biloba extract (GBE) is increasingly used to alleviate symptoms of age related cognitive impairment, with preclinical evidence pointing to a pro-cholinergic effect. While a number of behavioral studies have reported improvements to working memory (WM) associated with GBE, electrophysiological studies of GBE have typically been limited to recordings during a resting state. The current study investigated the chronic effects of GBE on steady state visually evoked potential (SSVEP) topography in nineteen healthy middle-aged (50-61 year old) male participants whilst completing an object WM task. A randomized double-blind crossover design was employed in which participants were allocated to receive 14 days GBE and 14 days placebo in random order. For both groups, SSVEP was recorded from 64 scalp electrode sites during the completion of an object WM task both pre- and 14 days post-treatment. GBE was found to improve behavioural performance on the WM task. GBE was also found to increase the SSVEP amplitude at occipital and frontal sites and increase SSVEP latency at left temporal and left frontal sites during the hold component of the WM task. These SSVEP changes associated with GBE may represent more efficient processing during WM task completion.

11.
Brain Topogr ; 22(3): 145-57, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19653091

ABSTRACT

While the neural regions associated with facial identity recognition are considered to be well defined, the neural correlates of non-moving and moving images of facial emotion processing are less clear. This study examined the brain electrical activity changes in 26 participants (14 males M = 21.64, SD = 3.99; 12 females M = 24.42, SD = 4.36), during a passive face viewing task, a scrambled face task and separate emotion and gender face discrimination tasks. The steady state visual evoked potential (SSVEP) was recorded from 64-electrode sites. Consistent with previous research, face related activity was evidenced at scalp regions over the parieto-temporal region approximately 170 ms after stimulus presentation. Results also identified different SSVEP spatio-temporal changes associated with the processing of static and dynamic facial emotions with respect to gender, with static stimuli predominately associated with an increase in inhibitory processing within the frontal region. Dynamic facial emotions were associated with changes in SSVEP response within the temporal region, which are proposed to index inhibitory processing. It is suggested that static images represent non-canonical stimuli which are processed via different mechanisms to their more ecologically valid dynamic counterparts.


Subject(s)
Cerebral Cortex/physiology , Emotions/physiology , Evoked Potentials, Visual/physiology , Facial Expression , Visual Perception/physiology , Adult , Attention , Brain Mapping , Discrimination, Psychological , Electroencephalography , Face , Female , Humans , Image Processing, Computer-Assisted , Male , Motion Perception , Pattern Recognition, Visual/physiology , Photic Stimulation , Signal Processing, Computer-Assisted
12.
J Atten Disord ; 6(4): 153-61, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12931073

ABSTRACT

The stop signal task (stop task) is designed to assess inhibitory control and is a frequently used research tool in clinical disorders such as ADHD and schizophrenia. Previous methods of setting stop signal delay and of assessing inhibitory control are problematic. The current study reports two modifications that improve the task as a measure of inhibitory control. The first modification was to set stop signal delays proportional to go mean reaction time (go MRT) to better account for inter-subject variability in go MRT. Twenty-eight normal children were tested, and all standard, stop task dependent measures were obtained when delays were set by this method. The second modification was to calculate a novel dependent measure called the area of inhibition (AOI) which provides a more complete measure of inhibitory control than the slope of the relative finishing time z-scores (ZRFT-slope). Implications for the assessment of inhibitory control in clinical populations are discussed.


Subject(s)
Inhibition, Psychological , Reaction Time , Self Efficacy , Attention Deficit Disorder with Hyperactivity , Child , Female , Humans , Male , Schizophrenia , Visual Perception
13.
Int J Psychophysiol ; 42(2): 219-32, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11587778

ABSTRACT

The steady state visually evoked potential (SSVEP) elicited by a diffuse 13-Hz visual flicker was recorded from 64 scalp sites in 30 subjects performing a low and high demand version of an object working memory task. During the perceptual component of the task, the SSVEP amplitude was reduced at left and right parieto-occipital sites. During the hold or memory component of the task, the SSVEP amplitude exhibited a load-dependent increase at frontal and occipito-parietal sites, while the SSVEP latency exhibited a load-dependent reduction at central and left frontal sites. We suggest that SSVEP amplitude changes index cortical information processing modes in that perceptual processes are associated with an SSVEP amplitude reduction, while holding information in active short-term or working memory is associated with an SSVEP amplitude increase. We also discuss changes in SSVEP amplitude and latency in terms of changes in the behavior of cortico-cortico and thalamo-cortico loops that utilize cortical layer I. Such cortico-cortico and thalamo-cortical loops are also proposed to constitute a neurophysiological mechanism for holding information in working memory.


Subject(s)
Brain Mapping/methods , Evoked Potentials, Visual/physiology , Memory/physiology , Adult , Biofeedback, Psychology/methods , Cerebral Cortex/physiology , Humans , Male , Neural Pathways/physiology , Photic Stimulation/methods , Thalamus/physiology
14.
Vis Neurosci ; 18(3): 401-6, 2001.
Article in English | MEDLINE | ID: mdl-11497416

ABSTRACT

Monkey electrophysiological and human neuroimaging studies indicate the existence of specialized neural systems for the perception and execution of actions. To date, the dynamics of these neural systems in humans have not been well studied. Here, we investigated the spatial and temporal behavior of human neural responses elicited to viewing motion of the face, hand, and body. Scalp event-related potentials (ERPs) were recorded in 20 participants viewing videotaped mouth (opening, closing), hand (closing, opening), and body stepping (forward, backward) movements. ERP peak differences within the movements of each body part were compared using topographical maps of voltage, voltage difference, and Student's t-test at ERP peak latencies. Predominantly temporoparietal negative ERPs occurred to motion of all body parts within 200 ms postmovement onset. Hand closure elicited a significantly greater negativity than opening, particularly in the left hemisphere. Vertex positive ERPs within 300 ms postmovement onset were elicited to hand and body motion. A significantly greater positivity occurred for the body stepping forward relative to stepping backward. The ERP topography was consistent with observed activation foci in human neuroimaging studies. Our data indicate that the neural activity of a system dedicated to the perception of high-level motion stimuli can rapidly differentiate between movements across and within body parts.


Subject(s)
Brain/physiology , Face/physiology , Hand/physiology , Motion Perception/physiology , Movement , Visual Perception/physiology , Walking , Adult , Brain Mapping , Evoked Potentials , Female , Humans , Videotape Recording
16.
Int J Psychophysiol ; 39(1): 79-85, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11120349

ABSTRACT

Converging evidence from event-related potential and functional brain imaging studies suggests that the brain activity at posterior regions of the frontal cortex can predict the strength of long-term memory traces. This study examined the relationship between posterior frontal steady-state visually evoked potential (SSVEP) latency changes and recognition memory after a delay of 7 days. Thirty-five female subjects viewed an 18-min television documentary program interspersed with 12 unfamiliar television advertisements while brain electrical activity was recorded from four pre-frontal, two posterior frontal and two occipital scalp sites. After 7 days, the recognition memory was tested for images coinciding with the 20 most prominent frontal SSVEP latency minima and maxima during the viewing of ten contiguous advertisements (advertisements 2-11). We found that images coinciding with posterior frontal latency minima were more likely to be recognized (58.7% recognition) than images coinciding with SSVEP latency maxima (45.3% recognition). Furthermore, the relationship between posterior frontal SSVEP latency and recognition performance after 7 days was only apparent at the left posterior frontal site. The correlation between the recognition performance and SSVEP latency evaluated at all eight sites reached significance only at the left posterior frontal site. These findings suggest that frontal SSVEP latency variations can be used to assess the strength of long-term memory encoding for naturalistic stimuli.


Subject(s)
Evoked Potentials, Visual/physiology , Prefrontal Cortex/physiology , Recognition, Psychology/physiology , Adult , Female , Humans , Middle Aged , Television
17.
Diagn Cytopathol ; 22(5): 304-7, 2000 May.
Article in English | MEDLINE | ID: mdl-10790238

ABSTRACT

Pemphigus vulgaris is an autoimmune disease characterized by acantholytic blisters and erosions involving the oral mucosa, skin, and less frequently other mucosal surfaces. Although the cytology of scrapings from the cutaneous and oral lesions has been well-documented, there are relatively few reports in the literature of the cytologic appearance of pemphigus on cervicovaginal smears. This report documents a case of pemphigus involving the cervix, in which the diagnosis was not known at the time of the cervical smear and biopsy. The cytologic features of this case and those in the literature are described in detail, highlighting the necessity of awareness of the disease and its presentation on cervicovaginal smears, in preventing an overdiagnosis of neoplasia.


Subject(s)
Cervix Uteri/pathology , Pemphigus , Adult , Female , Humans , Pemphigus/pathology , Pemphigus/physiopathology
18.
Clin Neurophysiol ; 111(5): 850-7, 2000 May.
Article in English | MEDLINE | ID: mdl-10802456

ABSTRACT

OBJECTIVES: To examine the latency topography of the steady-state visually evoked potential (SSVEP) in patients diagnosed with schizophrenia and normal controls while undertaking a visual vigilance task. METHODS: Twenty patients diagnosed with schizophrenia and 18 normal controls performed the A-X version of the continuous performance task (CPT A-X) where subjects are required to press a micro-switch on the unpredictable appearance of an 'X' that had been preceded by an 'A.' Brain electrical activity was recorded from 64 scalp sites and a 13 Hz spatially uniform visual flicker presented with the task was used to elicit a steady-state visually evoked potential (SSVEP). RESULTS: Following the appearance of the 'A' and 'X,' the control group demonstrated a transient SSVEP latency reduction at parietal and prefrontal sites. By contrast, the patients group showed no such SSVEP latency reduction. The prefrontal SSVEP latency changes in the 500 ms interval following the appearance of the 'X' were correlated with mean individual reaction time in both populations. CONCLUSIONS: We suggest that the SSVEP latency reduction may index excitatory processes and that the absence of prefrontal SSVEP latency reduction in schizophrenic patients may be a manifestation of reduced prefrontal activity or 'hypofrontality' observed with other neuroimaging modalities.


Subject(s)
Brain Mapping , Brain/physiology , Cognition/physiology , Evoked Potentials, Visual/physiology , Schizophrenia/physiopathology , Adult , Brain/physiopathology , Electroencephalography , Female , Humans , Male , Reaction Time , Reference Values
19.
Arch Gen Psychiatry ; 55(12): 1105-12, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9862554

ABSTRACT

BACKGROUND: Symptoms of attention-deficit/hyperactivity disorder (ADHD) have been associated with frontal lobe deficits. We used a novel brain electrical imaging method to investigate rapid and continuous changes in brain activity during the continuous performance task (CPT) in normal boys and in boys with ADHD. The amplitude and latency topography of the steady-state visually evoked potential (SSVEP) were examined while subjects performed the "X" version of the CPT (CPT-X; the reference task) and the "A-X" version of the CPT (CPT-AX). METHODS: Seventeen boys meeting DSM-III-R criteria for ADHD and 17 age-matched controls participated in the study. Brain electrical activity was recorded from 64 scalp sites. During the reference task, subjects pressed a microswitch on the unpredictable appearance of the letter X. During the CPT-AX, subjects were required to press the microswitch on the appearance of the letter X only if an A had preceded it. RESULTS: In the interval between the appearances of the A and the X of the correct trials of the CPT-AX, control boys showed transient reductions in SSVEP latency at right prefrontal sites. By contrast, boys with ADHD showed no change or an increase in prefrontal SSVEP latency at right prefrontal sites. CONCLUSION: Our results suggest increased speed of prefrontal neural processing in children without ADHD following a priming stimulus, and a deficit in such processes in children with ADHD.


Subject(s)
Attention Deficit Disorder with Hyperactivity/diagnosis , Brain Mapping , Evoked Potentials, Visual/physiology , Frontal Lobe/physiopathology , Neuropsychological Tests/statistics & numerical data , Adolescent , Attention Deficit Disorder with Hyperactivity/physiopathology , Child , Discrimination, Psychological , Form Perception , Humans , Intelligence Tests/statistics & numerical data , Male , Prefrontal Cortex/physiopathology , Probability , Psychomotor Performance , Reaction Time , Sex Factors
20.
Ann N Y Acad Sci ; 855: 625-7, 1998 Nov 30.
Article in English | MEDLINE | ID: mdl-9929659

ABSTRACT

The location, nature and characteristics of brain activity during detection and identification of odors are of importance if brain function techniques are to be of value to sensory systems. Steady state probe topography (SSPT) has been used in our laboratory to record steady state visual evoked potentials (SSVEP), which have demonstrated cognitive task-related changes in a variety of testing paradigms. The enhanced spatial (when using 64 channels) and temporal resolution (380 ms) of the system enable the brain electrical activity changes occurring before, during and after delivery of an odor to be examined. We have developed a system which can deliver odors during normal respiration and the accurate timing needed for SSVEP recordings. The system is based on the premise that a subject breathing butanol compared with filtered medical air will demonstrate SSVEP topographic changes associated with detection and identification of butanol. During our experiments the subject has either an air sample or an equal volume of butanol injected into the inspiratory airflow. These are randomized, and every breath has the same stimulus system with no known clues as to the differences apart from detection. The results from a panel of 10 female subjects--who all identified the butanol correctly--showed that butanol delivery resulted in sequences of changes in SSVEP topography (amplitude and latencies) which involved parietal, frontal and temporal regions. While consistent with other studies (parietal changes), our results revealed more dynamic temporal changes involving prefrontal and parietal regions at different periods around odor delivery.


Subject(s)
Brain Mapping , Brain/physiology , Smell/physiology , Butanols , Evoked Potentials , Female , Humans , Odorants
SELECTION OF CITATIONS
SEARCH DETAIL
...